RNS Number : 7037B
Induction Healthcare Group PLC
12 October 2020
Strategic Collaboration Between Cerner and Induction Healthcare
Value added reseller agreement: NHS Trusts who are Cerner clients can access Zesty products through their existing agreements
Improving patient experience: strategic collaboration to help NHS hospitals make it easier for patients to manage their outpatient appointments and correspondence online
Induction, a leading healthcare technology company that helps healthcare professionals deliver better care more efficiently, announces a strategic collaboration with Cerner Corporation (Nasdaq: CERN), a global health care technology company.
Zesty, Induction's market-leading patient portal for hospitals, and Cerner will develop a joint patient engagement solution to help NHS trusts deliver an easier, quicker and more efficient service for patients. This collaboration will closely align existing patient facing technology in the UK and Ireland, building on the benefits of Cerner's patient portal solution Healthelife℠ and Zesty's integration capability with Cerner's electronic health record (EHR), Cerner Millennium®.
NHS Trusts are expected to help patients manage outpatient appointments, complete remote care questionnaires, and view hospital correspondence on their own mobile phones - helping to reduce delays and costs associated with posting letters, reducing demands on administrative, medical and nursing staff, and significantly improving patient experience and access to care options.
As part of the value added reseller (VAR) agreement, NHS Trusts that are already Cerner clients will have access to Zesty's market-leading patient portal under their existing contractual arrangements.
Cerner is a leader in health care technology interoperability and embeds standards and guidance in support of open approaches to data sharing between systems. Cerner was one of the first signatories of techUK's Health and Social Care Interoperability Charter, co-founding the UK's INTEROpen interoperability industry group while championing FHIR® in the UK, and having been a long-time supporter of the Professional Records Standards Body, as well as its predecessor in the Royal College of Physicians.
This strategic collaboration has the potential to generate material revenues for Induction in the year ending 31 March 2022, in keeping with the company's strategic focus.
James Balmain, Joint-CEO of Induction Healthcare, said:
"It is a landmark moment for Zesty to be selected by Cerner in the UK and Ireland to jointly develop patient engagement solutions for NHS hospitals. Together, our organisations can provide staff and patients with world class digital tools to manage their care and operate more efficiently in the current environment of rapidly changing and unfamiliar conditions. The prospect of a patient facing platform that represents the best of Zesty and the best of Cerner will be game-changing for both existing and new Cerner customers."
Distie Profit, Managing Director of Cerner UK, said:
"We will all be patients at some stage in our life, which is why Cerner is committed to providing our clients with scalable and interoperable solutions that help them create the best possible experience for their patients. Helping patients become more engaged and empowered through access to their health information allows them to receive care remotely and better manage their health."
"This new collaboration with Zesty is expected to provide a more streamlined experience for both patients and health care professionals and reaffirms our commitment to improving the outcomes for all individuals by creating innovative solutions and collaborations to benefit our clients."
In the UK, Cerner's powerful, open and interoperable Cerner EHR is utilised by more than144,000 health and care professionals across 24 NHS Trusts to manage 1.5 million patients every month. Its Health Information Exchange (HIE) shares more than 19 million health records, and its population health intelligence platform, HealtheIntent®, is contracted to help clients proactively manage and improve the health of more than 9.5 million individuals.
ENQUIRIES
Induction Healthcare
Via FTI Consulting
Dr Hugo Stephenson, Joint Chief Executive Officer
James Balmain, Joint Chief Executive Officer
Numis Securities (Nominated Adviser and Broker)
+44 (0) 207 260 1000
James Black / Freddie Barnfield / Huw Jeremy / Matthew Jones
FTI Consulting
+44 (0) 203 727 1000
Jamie Ricketts / Elena Kalinskaya / Sam Purewal / Mary Whittow
About Induction
Induction Healthcare Group PLC is a leading healthcare technology company that helps healthcare professionals deliver better care more efficiently. The Group has three platforms, Induction [Switch] and MicroGuide, that support healthcare professionals in multiple markets, including the UK, Ireland, Australia & South Africa, plus Zesty, a leading provider of patient portals to NHS Hospitals in the UK.
Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps over 140,000 registered users in multiple territories to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.
The MicroGuide platform provides medical organisations with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. The platform helps over 170,000 registered users in multiple territories, including the majority of hospital trusts within the NHS.
The Zesty platform enables patients to manage their care direct from their smartphone. The Zesty patient portal removes the friction from everyday health related tasks, like booking and managing appointments, reading letters digitally and sharing copies of electronic medical records.
About Cerner
Cerner's health technologies connect people and information systems in thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities.
Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit Cerner.com, The Cerner Blog or connect on Facebook, Instagram, LinkedIn, Twitter or The Cerner Podcast. Nasdaq: CERN. Health care is too important to stay the same.
Trademark reference
Zesty and Induction Healthcare logos are registered trademarks of Induction Healthcare Group PLC. Cerner, Cerner Millennium and HealtheIntent are registered trademarks of Cerner Corporation or its affiliates.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
